EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

The Lancet Obstetrics, Gynaecology, & Women's Health

ISSN 3050-5038 · Elsevier BV

Latest articles

  1. Extended genotyping of human papillomavirus and AI-assisted cervical visual evaluation for prediction of cervical precancer in nine resource-limited settings (PAVE): a cross-sectional study

    Silvia de Sanjosé, Federica Inturrisi, Rebecca B Perkins, Didem Egemen, Ana Cecilia Rodriguez, Brian Befano, Diego Guillen, Jose Jeronimo, Nicole Campos, Ana Ribeiro, Olusegun Ajenifuja, Karen Yeates, Miriam Cremer, Andrew Goldstein, Huiwu Chen, Jacqueline Figueroa, Margaret Madeleine, Teresa Norris, Tainá Raiol, Clement Adepiti, Bariki Mchome, Karla Alfaro, Judith Norman, Clara Nordon, Jennifer Boyd-Morin, Christopher Clark, Scott Kinder, Jayashree Kalpathy-Cramer, Mark Schiffman, Silvia de Sanjosé, Federica Inturrisi, Rebecca B. Perkins, Didem Egemen, Ana Cecilia Rodriguez, Brian Befano, Diego Guillén, José Jerónimo, Nicole Campos, Ana Ribeiro, Olusegun Ajenifuja

    Published: 2026-11DOI: 10.1016/s3050-5038(26)00231-1

  2. Effects of oral bovine lactoferrin versus oral iron sulphate in iron-deficiency anaemia in pregnancy (LEAP1): a multicentre, double-blind, randomised, phase 3 trial

    Joanne M Said, Rachel L O'Connell, Rebecca M Reynolds, Emily Callandar, Michael J Dibley, Sajid Soofi, Sidrah Nausheen, Karen Baker, Amanda Henry, Raiyomand Dalal, Josephine G Laurie, Stephen Cole, Lourdes St George, Amanda E Dennis, Irena Idel, Jonathan Morris, Valeria Lanzarone, Angela Makris, Andrew J Martin, Anthony Keech, Alpana Ghadge, John Simes, Ben W Mol, William O Tarnow-Mordi

    Published: 2026-11DOI: 10.1016/s3050-5038(26)00262-1

  3. Ethnic disparities in stillbirth and the effect of maternal factors, antenatal ultrasound, and antenatally suspected small-for-gestational-age as a marker of enhanced antenatal surveillance in the UK (DESiGN): a secondary cohort analysis nested within a randomised trial

    Chivon Winsloe, James Elhindi, Matias C Vieira, Charles G Arcus, Sophie Relph, Annette Briley, Mark Johnson, Louise M Page, Andrew Shennan, Christoph Lees, Asma Khalil, Jane Sandall, Deborah A Lawlor, Andrew Copas, Dharmintra Pasupathy

    Published: 2026-11DOI: 10.1016/s3050-5038(26)00288-8

  4. Prescription non-steroidal anti-inflammatory drugs and venous thromboembolism among women aged 15–49 years using hormonal contraceptives: population-based self-controlled case series study from four European countries

    Xintong Li, Yuchen Guo, Xihang Chen, Albert Prats-Uribe, Anna Saura-Lazaro, Agustina Giuliodori, Anna Palomar-Cros, Antonella Delmestri, Elvira Bräuner, Hedvig Nordeng, Irene López-Sánchez, Nhung T H Trinh, Saeed Hayati, Susanne Bruun, Talita Duarte-Salles, Martí Català, Daniel Prieto-Alhambra

    Published: 2026-11DOI: 10.1016/s3050-5038(26)00289-x

  5. A comprehensive comparison of risk factors for epithelial ovarian cancer by histotype: a pooled analysis of individual participant data from the Ovarian Cancer Association Consortium

    Renhua Na, Susan Jordan, Hoda Anton-Culver, Elisa V Bandera, Linda S Cook, Daniel W Cramer, Anna DeFazio, Jennifer A Doherty, Renée T Fortner, Simon A Gayther, Ellen L Goode, Marc T Goodman, Holly R Harris, Estrid Høgdall, Claus K Høgdall, Allan Jensen, Susanne K Kjaer, Sun-Seog Kweon, Keitaro Matsuo, Usha Menon, Roger L Milne, Francesmary Modugno, Kirsten B Moysich, Rachel A Murphy, Sue K Park, Celeste Leigh Pearce, Paul D P Pharoah, Bo Qin, Harvey A Risch, Joellen M Schildkraut, Weiva Sieh, Rebecca Sutphen, Soo Hwang Teo, Kathryn L Terry, Anne M van Altena, Chen Wang, Nicolas Wentzensen, Stacey J Winham, Yin Ling Woo, Anna H Wu

    Published: 2026-11DOI: 10.1016/s3050-5038(26)00311-0

Volumes

2026 · 2452025 · 95

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.